NCT02390063 2020-02-10
Vaccination in Prostate Cancer (VANCE)
University of Oxford
Phase 1 Completed
Clinical Trials
6 trialsNCT02423928 2019-10-25
CryoIT
Alden Cancer Therapy II
Phase 1 Completed
NCT01303705 2018-08-29
Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer
Providence Health & Services
Phase 1 Completed
NCT01496131 2018-03-09
Tecemotide (L-BLP25) in Prostate Cancer
EMD Serono
Phase 2 Completed
NCT00176605 2014-05-20
Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer
Rutgers, The State University of New Jersey
Phase 2 Completed
NCT00381173 2013-05-14
A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing
Eisai Inc.
Phase 1 Completed